A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

The study did not provide ... (55 [53%] of 104). 1 Therefore, reduced venetoclax dose intensity might affect treatment outcomes, including complete remission rates and the duration and depth of ...

There are several types of leukemia, categorized by the speed of progression (acute or chronic) and the type of blood cell affected (lymphocytic or myeloid). The four main types are: Symptoms of ...

The cost of whole-genome sequencing is approaching that of the traditional genetic tests currently used for patients diagnosed with acute leukemia, according to a new study published in the ...

and to CB-012 for relapsed or refractory acute myeloid leukemia (r/r AML). CB-010, an allogeneic anti-CD19 CAR-T cell therapy, will be evaluated in the GALLOP Phase 1 clinical trial in patients ...

Sangeetha Venugopal, MD, MS, discusses the dynamic landscape of molecular targets in acute myeloid leukemia. The molecular landscape of acute myeloid leukemia (AML) is constantly changing. Genetic ...